US Stock MarketDetailed Quotes
DERM Journey Medical
- 5.320
- -0.850-13.78%
Close Nov 4 16:00 ET
- 5.460
- +0.140+2.63%
Post 20:02 ET
110.27MMarket Cap40.92P/E (TTM)
6.335High5.000Low894.72KVolume6.000Open6.170Pre Close5.22MTurnover8.72%Turnover RatioLossP/E (Static)20.73MShares8.11052wk High9.76P/B54.60MFloat Cap2.85052wk Low--Dividend TTM10.26MShs Float10.200Historical High--Div YieldTTM21.64%Amplitude1.020Historical Low5.837Avg Price1Lot Size
About Journey Medical Company
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Company Profile
SymbolDERM
Company NameJourney Medical
Listing DateNov 12, 2021
Issue Price10.00
Founded2014
CEOMr. Claude Maraoui
MarketNASDAQ
Employees58
Fiscal Year Ends12-31
Address9237 E Via de Ventura Boulevard,Suite 105
CityScottsdale
ProvinceArizona
CountryUnited States of America
Zip Code85258
Phone1-480-434-6670
Company Executives
- Name
- Position
- Salary
- Claude Maraoui
- Director, President and Chief Executive Officer
- 934.45K
- Joseph Benesch
- Chief Financial Officer and Corporate Controller
- 409.04K
- Dr. Lindsay A. Rosenwald, M.D.
- Executive Chairman of the Board
- 50.00K
- Michael C. Pearce
- Director
- --
- Justin Smith
- Independent Director
- 100.00K
- Neil Herskowitz
- Independent Director
- 110.00K
- Miranda Jayne Toledano
- Independent Director
- 100.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data